These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37298741)
1. Development and Validation of a New LC-MS/MS Bioanalytical Method for the Simultaneous Determination of Levodopa, Levodopa Methyl Ester, and Carbidopa in Human Plasma Samples. Molteni L; Charlier B; Izzo V; Coglianese A; Conti V; Eleopra R; Cilia R; Capelli C; D'Urso A; de Grazia U Molecules; 2023 May; 28(11):. PubMed ID: 37298741 [TBL] [Abstract][Full Text] [Related]
2. A new HILIC-MS/MS method for the simultaneous analysis of carbidopa, levodopa, and its metabolites in human plasma. Vilhena Rde O; Pontes FL; Marson BM; Ribeiro RP; de Carvalho KA; Cardoso MA; Pontarolo R J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 967():41-9. PubMed ID: 25063927 [TBL] [Abstract][Full Text] [Related]
3. Sensitive LC-MS/MS method for quantitation of levodopa and carbidopa in plasma: application to a pharmacokinetic study. Ferreira MS; Davanço MG; Pepi GT; Previde N; Gabbai JJ; Martho AC; Brandão AH; Riccio MF; de Campos DR; Meulman J; Noboli AC; Júnior PS Bioanalysis; 2018 Oct; 10(19):1567-1576. PubMed ID: 30295551 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a high-performance liquid chromatography-electrospray ionization-MS/MS method for the simultaneous quantitation of levodopa and carbidopa in human plasma. César IC; Byrro RM; Santana E Silva Cardoso FF; Mundim IM; Souza Teixeira L; Gomes SA; Bonfim RR; Pianetti GA J Mass Spectrom; 2011 Sep; 46(9):943-8. PubMed ID: 21915959 [TBL] [Abstract][Full Text] [Related]
5. Continuous versus intermittent oral administration of levodopa in Parkinson's disease patients with motor fluctuations: A pharmacokinetics, safety, and efficacy study. Warren Olanow C; Torti M; Kieburtz K; Leinonen M; Vacca L; Grassini P; Heller A; Heller E; Stocchi F Mov Disord; 2019 Mar; 34(3):425-429. PubMed ID: 30653246 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of an LC-MS/MS method for simultaneous quantification of levodopa and MD01 in rat plasma and its application to a pharmacokinetic study of mucuna pruriens extract. Yang G; Zhang F; Deng L; Chen C; Cheng Z; Huang J; Liu J; Jiang H Biomed Chromatogr; 2016 Sep; 30(9):1506-14. PubMed ID: 26928470 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease. Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a simple and sensitive method for quantification of levodopa and carbidopa in rat and monkey plasma using derivatization and UPLC-MS/MS. Junnotula V; Licea-Perez H J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():47-53. PubMed ID: 23548675 [TBL] [Abstract][Full Text] [Related]
9. Enantiomeric determination of DOPA in dietary supplements containing Mucuna pruriens by liquid chromatography/mass spectrometry. Hasegawa T; Takahashi K; Fukiwake T; Saijo M; Motoki Y Shokuhin Eiseigaku Zasshi; 2013; 54(5):379-83. PubMed ID: 24190293 [TBL] [Abstract][Full Text] [Related]
10. Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report. Radder DLM; Tiel Groenestege AT; Boers I; Muilwijk EW; Bloem BR J Parkinsons Dis; 2019; 9(2):437-439. PubMed ID: 30856121 [TBL] [Abstract][Full Text] [Related]
11. Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease. Verhagen Metman L; Stover N; Chen C; Cowles VE; Sweeney M Mov Disord; 2015 Aug; 30(9):1222-8. PubMed ID: 25847690 [TBL] [Abstract][Full Text] [Related]
12. Quantitation of levodopa and carbidopa in rat plasma by LC-MS/MS: The key role of ion-pairing reversed-phase chromatography. Chi J; Ling Y; Jenkins R; Li F J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1054():1-9. PubMed ID: 28412665 [TBL] [Abstract][Full Text] [Related]
13. A rapid liquid chromatography/tandem mass spectrometry method for simultaneous determination of levodopa, carbidopa, entacapone and their six related compounds in film-coated tablets. Burmaoğlu RE; Sağlık Aslan S Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8782. PubMed ID: 32170976 [TBL] [Abstract][Full Text] [Related]
14. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset. Tayarani-Binazir KA; Jackson MJ; Fisher R; Zoubiane G; Rose S; Jenner P Eur J Pharmacol; 2010 Jun; 635(1-3):109-16. PubMed ID: 20303948 [TBL] [Abstract][Full Text] [Related]
15. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma. Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease. Nomoto M; Nagai M; Nishikawa N; Ando R; Kagamiishi Y; Yano K; Saito S; Takeda A eNeurologicalSci; 2018 Dec; 13():8-13. PubMed ID: 30294682 [TBL] [Abstract][Full Text] [Related]
17. Simple and accurate quantitative analysis of cefiderocol and ceftobiprole in human plasma using liquid chromatography-isotope dilution tandem mass spectrometry: interest for their therapeutic drug monitoring and pharmacokinetic studies. Llopis B; Bleibtreu A; Schlemmer D; Robidou P; Paccoud O; Tissot N; Noé G; Junot H; Luyt CÉ; Funck-Brentano C; Zahr N Clin Chem Lab Med; 2021 Oct; 59(11):1800-1810. PubMed ID: 34243226 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease. Safirstein BE; Ellenbogen A; Zhao P; Henney HR; Kegler-Ebo DM; Oh C Clin Ther; 2020 Jun; 42(6):1034-1046. PubMed ID: 32482490 [TBL] [Abstract][Full Text] [Related]
19. Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety. Othman AA; Chatamra K; Mohamed ME; Dutta S; Benesh J; Yanagawa M; Nagai M Clin Pharmacokinet; 2015 Sep; 54(9):975-84. PubMed ID: 25875940 [TBL] [Abstract][Full Text] [Related]
20. Sensitivity improvement of the LC-MS/MS quantification of carbidopa in human plasma and urine by derivatization with 2,4-pentanedione. van de Merbel NC; Bronsema KJ; Gorman SH; Bakhtiar R J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1064():62-67. PubMed ID: 28915419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]